Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress

BACKGROUND: Miltefosine (MIL) is an oral antileishmanial drug used for treatment of visceral leishmaniasis (VL) in the Indian subcontinent. Recent reports indicate a significant decline in its efficacy with a high rate of relapse in VL as well as post kala-azar dermal leishmaniasis (PKDL). We invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Deep, Deepak Kumar, Singh, Ruchi, Bhandari, Vasundhra, Verma, Aditya, Sharma, Vanila, Wajid, Saima, Sundar, Shyam, Ramesh, V., Dujardin, Jean Claude, Salotra, Poonam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470736/
https://www.ncbi.nlm.nih.gov/pubmed/28575060
http://dx.doi.org/10.1371/journal.pntd.0005641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470736/
https://www.ncbi.nlm.nih.gov/pubmed/28575060
http://dx.doi.org/10.1371/journal.pntd.0005641

Ejemplares similares